6533b852fe1ef96bd12aabdb
RESEARCH PRODUCT
Need for Deprescribing in Hospital Elderly Patients Discharged with a Limited Life Expectancy: The REPOSI Study
L. PasinaB. B. OttoliniL. CortesiM. TettamantiC. FranchiA. MarengoniP. M. MannucciA. NobiliS. CorraoF. SalernoM. CesariF. PerticoneG. LicataF. VioliG. R. CorazzaI. ArdoinoD. PriscoE. SilvestriC. CenciG. EmmiG. BioloM. ZanettiM. GuadagniM. ZaccariM. VanoliG. GrignaniE. A. PulixiM. BernardiS. L. BassiL. SantiG. ZaccheriniE. MannarinoG. LupattelliV. BianconiF. PaciulloR. NutiR. ValentiM. RuvioS. CappelliA. PalazzuoliO. OlivieriD. GirelliT. MatteazziM. BarbagalloL. DominguezF. CocitaV. BeneduceL. PlancesM. ZoliI. LazzariM. BrunoriF. L. PasiniP. L. CapecchiG. PalascianoM. E. ModeoC. Di GennaroM. D. CappelliniD. MairaV. Di StefanoG. FabioS. SeghezziM. MancarellaP. D. RossiS. DamantiM. ClericiF. ContiE. MiceliM. V. LentiM. PisatiC. C. DominioniG. MurialdoA. MarraF. CattaneoM. B. SecchiD. GhelfiL. AnastasioL. SofiaM. CarboneF. CipolloneM. T. GuagnanoE. AngelucciE. ValerianiG. MancusoD. CalipariM. BartoneG. DelitalaM. BerriaM. MuscaritoliA. MolfinoE. PetrilloG. ZuccalaG. D'aurizioG. RomanelliA. ZucchelliA. PicardiU. V. GentilucciP. GalloC. Dell'untoG. AnnoniM. CorsiG. BellelliS. ZazzettaP. MazzolaH. SzaboA. BonfantiF. ArturiE. SuccurroM. RubinoM. G. SerraM. A. BleveL. GasbarroneM. R. SajevaA. BrucatoS. GhidoniF. FabrisI. BertozziG. BogoniM. V. RabuiniE. CosiR. ManfrediniF. FabbianB. BoariA. De GiorgiR. TiseoG. PaolissoM. R. RizzoC. BorghiE. StrocchiV. De SandoI. PareoC. SabbaF. S. VellaP. SuppressaP. AgostiA. SchilardiF. LoparcoL. FenoglioC. BraccoA. V. GiraudoS. FargionG. PeritiM. PorzioS. TiraboschiF. PeyvandiR. RossioB. FerrariG. ColomboV. MonzaniV. SavojardoC. FolliG. CerianiG. PalliniF. DallegriL. OttonelloL. LiberaleL. CaserzaK. SalamN. L. LiberatoT. TogninG. B. BianchiS. GiaquintoF. PurrelloA. Di PinoS. PiroR. RozziniL. FalangaE. SpazziniC. FerrandinaG. MontrucchioP. PetittiR. SalmiP. GaudenziL. PerriR. LandolfiM. MontaltoA. MirijelloL. GuastiL. CastiglioniA. MarescaA. SquizzatoM. MolaroA. GrossiM. BertolottiC. MussiM. V. LibbraG. DondiE. PellegriniL. CarulliL. ColangeloT. FalboV. StanghelliniR. De GiorgioE. RuggeriS. Del VecchioA. SalviR. LeonardiG. DamianiA. GabrielliW. CapeciM. MattioliG. P. MartinoL. BiondiP. PettinariR. GhioA. Dal ColS. MinisolaL. ColangeloA. AfeltraB. MariglianoM. E. PipitaP. CastellinoJ. BlancoL. ZanoliS. PignataroV. SaraccoM. FogliatiC. BussolinoF. MeteM. GinoA. CittadiniC. VigoritoM. ArcopintoA. SalzanoE. BobbioA. M. MarraD. SiricoG. MoreoF. GaspariniS. ProloG. PinaA. BallestreroF. FerrandoS. BerraS. DassiM. C. NavaB. GraziellaS. BaldassarreS. FragapaniG. GrudenG. GalantiG. MascheriniC. PetriL. StefaniM. GirinoV. PiccinelliF. NassoV. GioffreM. PasqualeG. ScattolinS. MartinelliM. TurrinL. SechiC. CatenaG. ColussiN. PassarielloL. RinaldiF. BertiG. FamularoT. PatriziaR. CastelloM. PasinoG. P. CedaM. G. MaggioS. MorgantiA. ArtoniS. Del GiaccoD. FirinuF. LosaG. PaolettiG. MontaltoA. LicataV. MalerbaL. AntoninoG. BasileC. AntoninoL. MalatinoB. StancanelliV. TerranovaS. Di MarcaP. MecocciC. RuggieroV. BoccardiT. MeschiF. LauretaniA. TicinesiP. MinuzL. FondrieschiM. PirisiG. P. FraD. SolaM. PortaP. RivaR. QuadriG. ScanziC. MengoliS. ProviniL. RicevutiE. SimeoneR. ScurtiF. TollosoR. TarquiniA. ValorianiS. DolentiG. VanniniA. TedeschiL. TrottaR. VolpiP. BocchiA. VignaliS. HarariC. LonatiM. CattaneoN. R. DuqueA. M. MolineroP. A. RequejoV. L. PelaezL. TamargoX. C. VirosF. FormigaJ. D. ManglanoE. B. TelloE. Del Corral BehamonteM. S. PurasM. RomeroB. P. LlorenteC. L. Gonzalez-cobosM. Victoria Villalba GarciaS. LopezJ. BoscoS. S. BaenaM. A. GallegoC. G. BecerraA. F. MoyanoM. G. HernandezM. P. BorregoR. P. CuadrosF. P. RojasB. G. OlidS. C. GarciaA. G. -C. CervelleraM. P. MartinezA. R. CanteroA. A. ArraigosaM. G. GuerreroM. A. B. RamosM. J. ManuelI. N. VeleiroL. A. SuarezA. LopezD. R. BranI. I. VazquezM. R. Pregosubject
0301 basic medicineDrugMalemedicine.medical_specialtyDeprescriptions020205 medical informaticsDrug-Related Side Effects and Adverse Reactionsmedia_common.quotation_subjectElderly; End of life; Limited life expectancy; Polypharmacy; Symptomatic medications; Aged 80 and over; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Italy; Male; Polypharmacy; Deprescriptions; Life Expectancy; Patient DischargeSocio-culturale02 engineering and technology03 medical and health sciencesElderly · End of life · Limited life expectancy · Polypharmacy · Symptomatic medicationsPharmacotherapyDeprescriptionsLife ExpectancyElderlySymptomatic medications0202 electrical engineering electronic engineering information engineeringmedicine80 and overHumansLS4_4Medical prescriptionElderly; End of life; Limited life expectancy; Polypharmacy; Symptomatic medicationsmedia_commonAgedPolypharmacyAged 80 and overOriginal Paperbusiness.industryGeneral MedicineElderly End-of-life Limited life expectancy Polypharmacy Preventing medications Symptomatic medicationsElderly End of life Limited life expectancy Polypharmacy Symptomatic medicationsPatient DischargeClonidineLimited life expectancyItalyEmergency medicineEnd of lifeLife expectancyPolypharmacyFemale030101 anatomy & morphologyDeprescribingbusinessmedicine.drugSymptomatic medicationdescription
<b><i>Objective:</i></b> Older people approaching the end of life are at a high risk for adverse drug reactions. Approaching the end of life should change the therapeutic aims, triggering a reduction in the number of drugs.<b><i></i></b>The main aim of this study is to describe the preventive and symptomatic drug treatments prescribed to patients discharged with a limited life expectancy from internal medicine and geriatric wards. The secondary aim was to describe the potentially severe drug-drug interactions (DDI). <b><i>Materials and Methods:</i></b> We analyzed Registry of Polytherapies Societa Italiana di Medicina Interna (REPOSI), a network of internal medicine and geriatric wards, to describe the drug therapy of patients discharged with a limited life expectancy. <b><i>Results:</i></b> The study sample comprised 55 patients discharged with a limited life expectancy. Patients with at least 1 preventive medication that could be considered for deprescription at the end of life were significantly fewer from admission to discharge (<i>n</i> = 30; 54.5% vs. <i>n</i> = 21; 38.2%; <i>p</i> = 0.02). Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, calcium channel blockers, lipid-lowering drugs, and clonidine were the most frequent potentially avoidable medications prescribed at discharge, followed by xanthine oxidase inhibitors and drugs to prevent fractures. Thirty-seven (67.3%) patients were also exposed to at least 1 potentially severe DDI at discharge. <b><i>Conclusion:</i></b> Hospital discharge is associated with a small reduction in the use of commonly prescribed preventive medications in patients discharged with a limited life expectancy. Cardiovascular drugs are the most frequent potentially avoidable preventive medications. A consensus framework or shared criteria for potentially inappropriate medication in elderly patients with limited life expectancy could be useful to further improve drug prescription.
year | journal | country | edition | language |
---|---|---|---|---|
2019-03-20 |